The originating document has been archived. We cannot confirm the completeness, accuracy and currency of the content.
ATC (Anatomical Therapeutic Chemical Classification)
CAS registry number (Chemical Abstracts Service)
Muscarinic receptor antagonist (anticholinergic, parasympatholytic agent)
Benzeneacetic acid, α-phenyl-, 1-etyl-3-piperidinyl ester
- Piperidolatum (Latin)
- Piperidolat (German)
- Pipéridolate (French)
- Piperidolato (Spanish)
- Piperidolate (OS: BAN)
- Pipéridolate (OS: DCF)
- Piperidolate Hydrochloride (OS: BANM, JAN)
- Piperidolate Hydrochloride (PH: USP XX)
Kissei Pharmaceutical, Japan
- Dactil OB
- Dactil-OB [+ Hesperidin, + Ascorbic Acid]
Sanofi-Aventis Farmaceutica, Brazil
Kyorin Pharmaceutical, Japan; Shinlin Sinseng, Taiwan
|BAN||British Approved Name|
|BANM||British Approved Name (Modified)|
|DCF||Dénomination Commune Française|
|JAN||Japanese Accepted Name|
|Rec.INN||Recommended International Nonproprietary Name (World Health Organization)|
Further information on drug naming conventions: International Nonproprietary Names.
Important Notice: The Drugs.com international database is in BETA release. This means it is still under development and may contain inaccuracies. It is not intended as a substitute for the expertise and judgement of your physician, pharmacist or other healthcare professional. It should not be construed to indicate that the use of any medication in any country is safe, appropriate or effective for you. Consult with your healthcare professional before taking any medication.
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.